1. Home
  2. PRMB vs RGEN Comparison

PRMB vs RGEN Comparison

Compare PRMB & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Primo Brands Corporation

PRMB

Primo Brands Corporation

HOLD

Current Price

$19.64

Market Cap

8.0B

Sector

N/A

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$186.75

Market Cap

10.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRMB
RGEN
Founded
1955
1981
Country
United States
United States
Employees
N/A
2000
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
10.0B
IPO Year
2025
1995

Fundamental Metrics

Financial Performance
Metric
PRMB
RGEN
Price
$19.64
$186.75
Analyst Decision
Buy
Buy
Analyst Count
9
12
Target Price
$24.00
$167.67
AVG Volume (30 Days)
4.2M
853.9K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
2.49%
N/A
EPS Growth
328.57
286.96
EPS
0.26
0.24
Revenue
$6,664,000,000.00
$141,236,000.00
Revenue This Year
$2.34
$14.30
Revenue Next Year
$3.56
$14.52
P/E Ratio
$78.77
$752.96
Revenue Growth
29.34
35.10
52 Week Low
$14.36
$100.99
52 Week High
$26.21
$188.73

Technical Indicators

Market Signals
Indicator
PRMB
RGEN
Relative Strength Index (RSI) 40.96 62.97
Support Level $20.36 $158.15
Resistance Level $21.33 $188.73
Average True Range (ATR) 0.87 5.68
MACD -0.03 0.33
Stochastic Oscillator 15.15 94.17

Price Performance

Historical Comparison
PRMB
RGEN

About PRMB Primo Brands Corporation

Primo Brands Corp is a North American branded beverage company focused on healthy hydration. It delivers sustainably and domestically sourced diversified offerings across products, formats, channels, price points, and consumer occasions, distributed in every state and Canada. Primo Brands is in reusable packaging, helping to reduce waste through its reusable, multi-serve bottles and brand packaging portfolio, which includes recycled plastic, aluminum, and glass.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: